1241.21.49005 Boehringer Ingelheim Investigational Site

Esslingen am Neckar

0 studies enrolling now · 1 studies all time

What they study most

Hepatitis C, Chronic

Studies at this site

• Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection — Completed